ArticlePharmaceutical research2022
A Charge Variant of Bevacizumab Offers Enhanced FcRn-Dependent Pharmacokinetic Half-Life and Efficacy.
Sumit K Singh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticlePharmaceutical research2022
Sumit K Singh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.